Lilly projects sharp drop in 2012 profit
by on Jan.05, 2012, under Health and Fitness
(Reuters) – Eli Lilly & Co forecast a steeper-than-expected decline in profit for 2012, the first full year without exclusive rights to its big-selling Zyprexa schizophrenia treatment. Shares fell 3.5 percent after Lilly announced its forecast on …
View full post on Yahoo! Health News
